Core Alternative Capital Merck & Co., Inc. Transaction History

Core Alternative Capital

$359 Million
Q2 2025

A detailed history of Core Alternative Capital transactions in Merck & Co., Inc. stock. As of the latest transaction made, Core Alternative Capital holds 50,709 shares of MRK stock, worth $4.03 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

50,709

Previous 58,963 14.0%

Holding current value

$4.03 Million

Previous $5.29 Million 24.15%

% of portfolio

1.12%

Previous 1.35%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$73.47 - $87.12 $606,421 - $719,088	-8,254 Reduced 14.0%	50,709 $4.01 Million
Q1 2025 Apr 29, 2025	SELL	$83.01 - $101.02 $948,223 - $1.15 Million	-11,423 Reduced 16.23%	58,963 $5.29 Million
Q4 2024 Jan 29, 2025	SELL	$96.31 - $114.76 $294,804 - $351,280	-3,061 Reduced 4.17%	70,386 $7 Million
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $722,141 - $837,918	-6,497 Reduced 8.13%	73,447 $8.34 Million
Q2 2024 Aug 16, 2024	SELL	$123.8 - $132.96 $1.25 Million - $1.34 Million	-10,101 Reduced 11.22%	79,944 $9.9 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $2.31 Million - $2.69 Million	-20,408 Reduced 18.48%	90,045 $11.9 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $2.59 Million - $2.82 Million	-25,866 Reduced 18.97%	110,453 $12 Million
Q3 2023 Oct 19, 2023	SELL	$102.95 - $114.33 $395,328 - $439,027	-3,840 Reduced 2.74%	136,319 $14 Million
Q2 2023 Jul 27, 2023	SELL	$108.61 - $118.38 $3.14 Million - $3.43 Million	-28,947 Reduced 17.12%	140,159 $16.2 Million
Q1 2023 Apr 18, 2023	SELL	$102.94 - $114.86 $400,436 - $446,805	-3,890 Reduced 2.25%	169,106 $18 Million
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $1.67 Million - $2.14 Million	19,048 Added 12.37%	172,996 $19.2 Million
Q3 2022 Oct 18, 2022	BUY	$84.53 - $94.96 $5.06 Million - $5.69 Million	59,884 Added 63.66%	153,948 $13.3 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $1.38 Million - $1.57 Million	16,574 Added 21.39%	94,064 $8.58 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $1.6 Million - $1.79 Million	-21,726 Reduced 21.9%	77,490 $6.36 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $196,673 - $246,359	2,721 Added 2.82%	99,216 $7.53 Million
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $687,339 - $755,900	9,589 Added 11.03%	96,495 $7.25 Million
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $1.06 Million - $1.17 Million	15,095 Added 21.02%	86,906 $6.76 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $464,254 - $546,843	6,742 Added 10.36%	71,811 $5.54 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $474,973 - $527,123	6,618 Added 11.32%	65,069 $5.32 Million
Q3 2020 Oct 09, 2020	SELL	$73.18 - $82.95 $406,441 - $460,704	-5,554 Reduced 8.68%	58,451 $4.85 Million
Q2 2020 Jul 13, 2020	BUY	$70.42 - $80.13 $90,278 - $102,726	1,282 Added 2.04%	64,005 $4.95 Million
Q1 2020 Jun 09, 2020	BUY	$63.36 - $87.82 $2.33 Million - $3.23 Million	36,830 Added 142.24%	62,723 $4.83 Million
Q4 2019 Jun 05, 2020	BUY	$77.58 - $87.54 $2.01 Million - $2.27 Million	25,893 New	25,893 $2.35 Million

Others Institutions Holding MRK

# of Institutions

3,874

Shares Held

1.92B

Call Options Held

25.7M

Put Options Held

24.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $201B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.

Account

Core Alternative Capital Merck & Co., Inc. Transaction History